home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Oncology Biomarkers

 
  November 17, 2010  
     
 
GTC Bio, San Diego, CA
Jan 27-28 2011


Please refer to the link provided for detailed agenda.
 
 
Organized by: GTCbio
Invited Speakers:

Carolyn Compton, M.D., Ph.D. - Featured Speaker
Director of the Office of Biorepositories and Biospecimen Research
National Cancer Institute


Stefano Bertuzzi, Ph.D.
 - Featured Speaker
Director, Science Policy
Office of the Director
National Institutes of Health

Jamila Louahed, Ph.D. - Featured Speaker
Director, Head of Research and Development
Cancer Immunotherapeutics
GlaxoSmithKline Biologicals

Dan Chelsky, Ph.D.
Chief Scientific Officer
Caprion

Timothy R. Church
Professor, Environmental Health Sciences
School of Public Health 
University of Minnesota

Lisa Freeman-Cook, Ph.D.
Senior Research and Development Manager
Life Technologies

Jerome Galon
Research Director 
Chief, Integrative Cancer Immunology Laboratory
Inserm 


Denise Geiger, Ph.D.
Director
John T. Mather Memorial Hospital

Andrew Grupe, Ph.D
Senior Director, Pharmacogenomics
Celera

Leif Hakansson, M.D., Ph.D.
Associate Professor, Vice Chairman BDA
Chairman of the BDA Immunotherapy Working Group
CEO, CanImGuide Therapeutics AB 

Dave S.B. Hoon
, Ph.D
Director, Molecular Oncology

John Wayne Cancer Institute

Stephen Johnston, Ph.D.
Director, Center for 
Innovations in Medicine
The Biodesign Institute 
Arizona State University

Myla Lai-Goldman
Chief Executive Officer
CancerGuide Diagnostics


Thomas Li, Ph.D., FACB, FAAAAI
Senior Director, Technology Management
US Chief Technology Office
F. Hoffmann-La Roche Ltd

Stephen Little, Ph.D.
Vice President
Personalized Healthcare
DxS Diagnostics

Andrey Loboda, Ph.D.
Oncology Molecular Profiling
Merck Laboratories

Anna Lokshin, Ph.D. 
Associate Professor
University of Pittsburgh

Diane Longo
Scientist
Nodality

Raj Puri, M.D. Ph.D.
Director, Division of Cellular and Gene Therapies
Office of Cellular, Tissue and Gene Therapies
FDA/CBER

Nathalie Scholler, M.D., Ph.D
Assistant Professor
Obstetrics and Gynecology
University of Pennsylvania School of Medicine

Ginette Serrero, Ph.D.
Chief Executive Officer
A&G Pharmaceutical

Anthony P. Shuber
Chief Technology Officer, Co-Founder
Predictive Biosciences

Alan Spatz, M.D.
Director,Pathology Department
Jewish General Hospital
Professor, Pathology and Oncology
McGill University

Shabnam Tangri, Ph.D.
Director, Clinical Science and Technology
Biogen Idec

Ali Torkamani, Ph.D.
Assistant Professor
Molecular and Experimental Medicine 
Scripps Research Institute

Wim Van Criekinge, Ph.D.
Vice President, Science and Technology
MDxHealt

 
Deadline for Abstracts: N/A
 
Registration: http://gtcbio.com/conferenceDetails.aspx?id=142
E-mail: customerservices@gtcbio.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.